(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ECI THERAPEUTICS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ECI THERAPEUTICS

ST13

US500000098207252

Class

5

Filing

98207252

Registration

8233030

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

04/28/2026

Trademark type

Combined

Nice classes

5

Filing date

10/03/2023

Registration date

04/28/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/28/2026

Last transaction

04/28/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/30/2026

First use in commerce

01/30/2026

Drawing code

3

Owner type

16

Owner location

Garden City, NY, US

Examiner

GALBO, AMANDA

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized lettering “ECI” in black. Below the lettering “ECI” is a design of a horizontal bar with rounded ends. The bar is shaded, from left to right, in bands of red, green, yellow, and blue. Below the bar design is the stylized wording “THERAPEUTICS” in black. All the aforementioned wording and design elements are imposed on a transparent background. The color white represents transparent space and is not claimed as a feature of the mark.

Holders and representatives

Holders

Eye Care International , LLC

Representatives

Gene Bolmarcich Law Offices Of Gene Bolmarcich

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of eye diseases and conditions

Publications

History of USPTO decisions and trademark events.

52 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/28/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/28/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/08/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/07/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/07/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/07/2026

EX3G

SOU EXTENSION 3 GRANTED

04/07/2026

IUAF

USE AMENDMENT FILED

03/26/2026

EISU

TEAS STATEMENT OF USE RECEIVED

03/26/2026

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

03/26/2026

NREV

NOTICE OF REVIVAL - E-MAILED

03/26/2026

PETG

PETITION TO REVIVE-GRANTED

03/26/2026

PROA

TEAS PETITION TO REVIVE RECEIVED

03/26/2026

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

03/23/2026

ABN6

ABANDONMENT - NO USE STATEMENT FILED

03/23/2026

EXT3

SOU EXTENSION 3 FILED

02/19/2026

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/23/2025

EX2G

SOU EXTENSION 2 GRANTED

10/22/2025

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

10/15/2025

NREV

NOTICE OF REVIVAL - E-MAILED

10/15/2025

PETG

PETITION TO REVIVE-GRANTED

10/15/2025

PROA

TEAS PETITION TO REVIVE RECEIVED

10/15/2025

MAB6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

09/22/2025

ABN6

ABANDONMENT - NO USE STATEMENT FILED

09/22/2025

EXT2

SOU EXTENSION 2 FILED

08/19/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/28/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/28/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/28/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/24/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/24/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/24/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/21/2025

EX1G

SOU EXTENSION 1 GRANTED

05/20/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/19/2025

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

03/11/2025

NREV

NOTICE OF REVIVAL - E-MAILED

03/11/2025

PETG

PETITION TO REVIVE-GRANTED

03/11/2025

PROA

TEAS PETITION TO REVIVE RECEIVED

03/11/2025

EXT1

SOU EXTENSION 1 FILED

02/19/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/25/2024

PUBO

PUBLISHED FOR OPPOSITION

06/25/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/05/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/23/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/23/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/23/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/23/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/23/2024

DOCK

ASSIGNED TO EXAMINER

05/23/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

10/14/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/14/2023

NWAP

NEW APPLICATION ENTERED

10/03/2023

Continuous trademark protection

Get notified about every new filing that threatens ECI THERAPEUTICS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.